Zifo
Who is this analysis report for?
- Toxicologists, Pathologists, Bioanalysts and others involved in creating data for in-vivo/animal studies
- Those responsible for submission of INDs or NDAs of in-vivo studies
What you will get out of this report?
- Learn how CDISC SEND standardization and FAIR go hand-in-hand
- Understand the benefits of FAIRification of data
- Typical challenges to look out for in your standardization journey
Aishwarya Balajee
Head of Digital Solutions, North America Passionate about accelerating Science. Helping customers define and implement a Digital Strategy Expertise - Strategic consulting across R&D spectrum
Rimgaile Lukosiunaite
Business System Analyst at Zifo RnD Solutions for a big pharma client in North Chicago. She holds a dual BS in Biology and Exercise Science from Loyola University of Chicago and a MS in Biotechnology from Northwestern University. Rimgaile took courses in Pharmaceutical, Biotech and Medical Device Business Management, Marketing & Strategy from Kellogg School of Management during her MS program. Rimgaile has worked on various projects in Instrument Data Integrity Remediation, Gap Analysis and Validation & Qualification Activities. Over the last year, she has led implementation of regulatory standards on non-clinical data submissions at a big pharma company.
Aishwarya Balajee
Head of Digital Solutions, North America Passionate about accelerating Science. Helping customers define and implement a Digital Strategy Expertise - Strategic consulting across R&D spectrum
Rimgaile Lukosiunaite
Business System Analyst at Zifo RnD Solutions for a big pharma client in North Chicago. She holds a dual BS in Biology and Exercise Science from Loyola University of Chicago and a MS in Biotechnology from Northwestern University. Rimgaile took courses in Pharmaceutical, Biotech and Medical Device Business Management, Marketing & Strategy from Kellogg School of Management during her MS program. Rimgaile has worked on various projects in Instrument Data Integrity Remediation, Gap Analysis and Validation & Qualification Activities. Over the last year, she has led implementation of regulatory standards on non-clinical data submissions at a big pharma company.